Conversion of abiraterone to D4A drives antitumor activity in prostate cancer

Prostate cancer resistance to castration occurs because tumors acquire the metabolic capability of converting precursor steroids to 5α-dihydrotestosterone (DHT), promoting signaling by the androgen receptor (AR) and the development of castration-resistant prostate cancer (CRPC)(1–3). Essential for r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenfei, Bishop, Andrew, Alyamani, Mohammad, Garcia, Jorge A., Dreicer, Robert, Bunch, Dustin, Liu, Jiayan, Upadhyay, Sunil K., Auchus, Richard J., Sharifi, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506215/
https://www.ncbi.nlm.nih.gov/pubmed/26030522
http://dx.doi.org/10.1038/nature14406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506215/
https://www.ncbi.nlm.nih.gov/pubmed/26030522
http://dx.doi.org/10.1038/nature14406

Ejemplares similares